This Week in Science

In Science this week, a team led by Broad Institute scientists present a new version of the genome-editing technology CRISPR/Cas9 that can be used to diagnose infections, and potentially cancer, with high sensitivity. The researchers used a form of CRISPR that targets RNA and, when it binds to its target, activates its Cas enzyme to promiscuously cleave nearby RNA.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.